RI HB 7814
died on adjournmentAN ACT RELATING TO FOOD AND DRUGS -- PRESCRIPTION BENEFIT MANAGER ACCOUNTABILITY ACT
Rhode Island · 2026 Regular Session · lower
Quick answers
Did RI HB 7814 pass?
No. RI HB 7814 died when the 2026 Regular Session adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2026-02-26): 02/26/2026 Introduced, referred to House Health & Human Services
What is RI HB 7814 about?
Requires prescription benefit managers to approve a specific medication prescribed by a doctor when supported by a notarized medical necessity letter and requires that any denial be reviewed and documented by a licensed medical expert.
Who sponsors RI HB 7814?
Lima is the primary sponsor of RI HB 7814.
Description
Requires prescription benefit managers to approve a specific medication prescribed by a doctor when supported by a notarized medical necessity letter and requires that any denial be reviewed and documented by a licensed medical expert.
- Introduced
- 2026-02-26
- Latest action
- 2026-02-26 — 02/26/2026 Introduced, referred to House Health & Human Services
- Bill type
- bill
- Last updated
- —
Sponsors
- Limaprimary
Committees
Not provided by source.
Action timeline
2026-02-26
02/26/2026 Introduced, referred to House Health & Human Services
introduction,referral-committee
Versions
- 7814Compare
Documents
Votes
Not provided by source.
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:31:46.990152Z
Inspect retained evidence for changes recorded after evidence tracking began:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=RI&identifier=HB 7814. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.